X4 Pharmaceuticals Stock Quote XFOR - Stock Price, News, Charts, Message Board, Trades

Professional-Grade Tools, for Individual Investors.

Premium

Current Price

0.86

Bid

0.86

Ask

0.88

Volume

1,067,831

0.8328 Day's Range 0.89

0.5311 52 Week Range 1.88

Market Cap

144.426M

Previous Close

0.8648

Open

0.89

Last Trade

0.8799

Last Trade Time

Financial Volume

$ 924,206

VWAP

0.865499

Average Volume (3m)

2,185,617

Shares Outstanding

167,937,781

Dividend Yield

PE Ratio

-1.43

Earnings Per Share (EPS)

-0.6

Revenue

Net Profit

-101.17M

X4 Pharmaceuticals Inc is clinical-stage biopharmaceutical company. It is focused on restoring the immune system function by developing therapeutics for the treatment of rare diseases. Its molecule therapeutics are antagonists of chemokine receptor CXCR4, which have the potential to treat a broad ra... X4 Pharmaceuticals Inc is clinical-stage biopharmaceutical company. It is focused on restoring the immune system function by developing therapeutics for the treatment of rare diseases. Its molecule therapeutics are antagonists of chemokine receptor CXCR4, which have the potential to treat a broad range of rare diseases, including primary immunodeficiencies (PIs) and cancer. Its product candidate, X4P-001, has completed a Phase 2 trial in patients with a rare genetic PI called Warts. The company is also developing X4P-002, a CXCR4 antagonist that has properties that could enable penetration of the blood-brain barrier and provide appropriate therapeutic exposures to treat brain cancers, including glioblastoma multiforme. Show more

Sector

Biological Pds,ex Diagnstics

Industry

Biological Pds,ex Diagnstics

Website

www.x4pharma.com

Headquarters

Wilmington, Delaware, USA

Founded

1970

X4 Pharmaceuticals Inc is listed in the Biological Pds,ex Diagnstics sector of the NASDAQ with ticker XFOR. The last closing price for X4 Pharmaceuticals was $0.86. Over the last year, X4 Pharmaceuticals shares have traded in a share price range of $ 0.5311 to $ 1.88.

X4 Pharmaceuticals currently has 167,937,781 shares outstanding. The market capitalization of X4 Pharmaceuticals is $145.23 million. X4 Pharmaceuticals has a price to earnings ratio (PE ratio) of -1.43.

Period	Change	Change %	Open	High	Low	Avg. Daily Vol	VWAP
1	0.0975	12.7868852459	0.7625	0.8986	0.7275	1445010	0.81927944	CS
4	0.2509	41.1919225086	0.6091	0.8986	0.5311	2295560	0.66352016	CS
12	-0.25	-22.5225225225	1.11	1.2	0.5311	2185617	0.85765592	CS
26	0.12	16.2162162162	0.74	1.6	0.5311	2602010	1.04926306	CS
52	-0.93	-51.9553072626	1.79	1.88	0.5311	2360542	1.01335866	CS
156	-4.93	-85.1468048359	5.79	6.21	0.5311	1516119	1.36262905	CS
260	-11.7	-93.152866242	12.56	15.95	0.5311	945081	1.66422043	CS

Most Active
% Gainers
% Losers

Symbol	Price	Vol.
WINTWindtree Therapeutics Inc	$ 8.24 (150.46%)	48.57M
BFIBurgerFi International Inc	$ 0.4206 (97.37%)	313.59M
NBSTWNewbury Street Acquisition Corporation	$ 0.1349 (92.71%)	122.1k
YIBOPlanet Image International Ltd	$ 2.915 (53.43%)	259.77k
CREVCarbon Revolution Public Ltd	$ 9.00 (45.87%)	8.06M
NMHINatures Miracle Holding Inc	$ 0.2035 (-48.06%)	7.69M
TANHTantech Holdings Ltd	$ 0.2585 (-47.23%)	6.75M
DXCMDexCom Inc	$ 64.00 (-40.66%)	53.92M
PSIGPS International Group Ltd	$ 1.42 (-31.40%)	716.26k
POAIPredictive Oncology Inc	$ 1.36 (-27.27%)	6.02M
SLNASelina Hospitality PLC	$ 0.0305 (-18.88%)	408.61M
BFIBurgerFi International Inc	$ 0.4206 (97.37%)	313.59M
NVDANVIDIA Corporation	$ 113.06 (0.69%)	293.33M
SQQQProShares UltraPro Short QQQ	$ 9.10 (-2.88%)	176.49M
SGMOSangamo Therapeutics Inc	$ 0.8612 (28.15%)	123.71M